| Literature DB >> 26033034 |
Peng Mi1,2,3, Novriana Dewi4, Hironobu Yanagie4, Daisuke Kokuryo5, Minoru Suzuki6, Yoshinori Sakurai6, Yanmin Li7, Ichio Aoki5, Koji Ono6, Hiroyuki Takahashi4, Horacio Cabral7, Nobuhiro Nishiyama1,2, Kazunori Kataoka1,3,7,8.
Abstract
Gadolinium (Gd) chelates-loaded nanocarriers have high potential for achieving magnetic resonance imaging (MRI)-guided Gd neutron capture therapy (GdNCT) of tumors. Herein, we developed calcium phosphate micelles hybridized with PEG-polyanion block copolymers, and incorporated with the clinical MRI contrast agent Gd-diethylenetriaminepentaacetic acid (Gd-DTPA/CaP). The Gd-DTPA/CaP were nontoxic to cancer cells at the concentration of 100 μM based on Gd-DTPA, while over 50% of the cancer cells were killed by thermal neutron irradiation at this concentration. Moreover, the Gd-DTPA/CaP showed a dramatically increased accumulation of Gd-DTPA in tumors, leading to the selective contrast enhancement of tumor tissues for precise tumor location by MRI. The enhanced tumor-to-blood distribution ratio of Gd-DTPA/CaP resulted in the effective suppression of tumor growth without loss of body weight, indicating the potential of Gd-DTPA/CaP for safe cancer treatment.Entities:
Keywords: MRI; calcium phosphate micelle; drug delivery system; gadolinium neutron capture therapy
Mesh:
Substances:
Year: 2015 PMID: 26033034 DOI: 10.1021/acsnano.5b00532
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881